Free Trial

Nutrien Ltd. (NYSE:NTR) Shares Acquired by Northern Trust Corp

Nutrien logo with Basic Materials background

Northern Trust Corp boosted its stake in Nutrien Ltd. (NYSE:NTR - Free Report) by 59.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 356,031 shares of the company's stock after buying an additional 132,601 shares during the quarter. Northern Trust Corp owned approximately 0.07% of Nutrien worth $15,932,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of NTR. Moody National Bank Trust Division lifted its stake in Nutrien by 127.1% in the 4th quarter. Moody National Bank Trust Division now owns 13,698 shares of the company's stock valued at $613,000 after buying an additional 7,665 shares in the last quarter. FNY Investment Advisers LLC purchased a new position in Nutrien in the 4th quarter valued at about $111,000. 180 Wealth Advisors LLC lifted its stake in Nutrien by 7.1% in the 4th quarter. 180 Wealth Advisors LLC now owns 7,144 shares of the company's stock valued at $320,000 after buying an additional 471 shares in the last quarter. Covea Finance lifted its stake in Nutrien by 21.9% in the 4th quarter. Covea Finance now owns 55,600 shares of the company's stock valued at $2,485,000 after buying an additional 10,000 shares in the last quarter. Finally, Foundation Resource Management Inc. acquired a new stake in Nutrien in the 4th quarter valued at about $7,744,000. 63.10% of the stock is owned by hedge funds and other institutional investors.

Nutrien Stock Up 0.8%

Shares of Nutrien stock traded up $0.46 during trading on Friday, hitting $57.92. 1,752,913 shares of the stock were exchanged, compared to its average volume of 2,141,606. The stock has a market cap of $28.28 billion, a price-to-earnings ratio of 42.28, a price-to-earnings-growth ratio of 1.19 and a beta of 0.79. The firm's 50-day moving average price is $52.62 and its 200 day moving average price is $50.29. Nutrien Ltd. has a 12-month low of $43.70 and a 12-month high of $60.87. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82.

Nutrien (NYSE:NTR - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.11 earnings per share for the quarter, missing analysts' consensus estimates of $0.35 by ($0.24). Nutrien had a net margin of 2.62% and a return on equity of 6.81%. The company had revenue of $4.67 billion during the quarter, compared to analysts' expectations of $5.16 billion. During the same period last year, the firm earned $0.46 earnings per share. Nutrien's revenue was down 5.4% on a year-over-year basis. As a group, analysts forecast that Nutrien Ltd. will post 3.72 earnings per share for the current fiscal year.

Nutrien Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 18th. Shareholders of record on Monday, June 30th will be paid a $0.545 dividend. The ex-dividend date is Monday, June 30th. This represents a $2.18 dividend on an annualized basis and a yield of 3.76%. Nutrien's dividend payout ratio is presently 203.74%.

Analyst Upgrades and Downgrades

A number of analysts have commented on NTR shares. Bank of America increased their price objective on shares of Nutrien from $60.00 to $63.00 and gave the company a "buy" rating in a report on Wednesday. Scotiabank reiterated a "sector perform" rating and issued a $62.00 price objective on shares of Nutrien in a report on Wednesday. Oppenheimer increased their price objective on shares of Nutrien from $58.00 to $63.00 and gave the company an "outperform" rating in a report on Tuesday, May 13th. Mizuho raised their price target on shares of Nutrien from $52.00 to $55.00 and gave the stock a "neutral" rating in a report on Thursday, February 20th. Finally, Berenberg Bank raised their price target on shares of Nutrien from $54.00 to $59.00 and gave the stock a "buy" rating in a report on Tuesday, April 15th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $61.44.

View Our Latest Stock Report on NTR

Nutrien Profile

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Featured Articles

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Should You Invest $1,000 in Nutrien Right Now?

Before you consider Nutrien, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.

While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

New AI Deals Just Sent These 4 Infrastructure Stocks Soaring
7 Nuclear Stocks One Announcement Away from Exploding
3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines